Futur Health vs Maximus: Compare GLP-1 Programs & Pricing
Side-by-side Futur Health and Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Futur Health and Maximus are two telehealth providers that help patients access GLP-1–based weight management options, including semaglutide and tirzepatide formulations. This comparison focuses on pricing, membership requirements, clinical oversight, medication sourcing, and what to expect from each platform to help you make an informed choice.
Visit Futur Health
Explore Maximus
Futur Health vs Maximus: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Futur Health | $299.00 | $399.00 | 99 — Yes | |
| Maximus | $132.99 | — No |
Futur Health vs Maximus: Medical Process & Accessibility
Futur Health typically emphasizes a streamlined telehealth intake with clinician review to determine eligibility, prescriptions, and dosing. Maximus also operates virtually and is noted for structured follow-ups and dose adjustments. Both require medical histories, vital information, and clinician evaluation before any prescription is issued.
Futur Health vs Maximus: Pricing Comparison
Futur Health lists semaglutide starting at $299.00 and tirzepatide at $399.00. Maximus lists tirzepatide from $132.99 and does not display a semaglutide starting price in the published values here. Where a lower price is available, it is highlighted for clarity: semaglutide – $299.00 (Futur Health), tirzepatide – $132.99 (Maximus).
Membership and program fees also change the effective cost. Futur Health indicates a membership fee of $99 that is required, while Maximus shows no required membership fee. Factor membership, shipping, and any additional consult or lab fees into the total monthly or per-prescription cost before enrolling.
Futur Health vs Maximus: Clinical Oversight & Safety
Both providers pair patients with licensed U.S. clinicians who review medical history and determine appropriate therapy. Telehealth evaluation can include intake forms, virtual visits, and recommended monitoring. Providers should exclude patients with contraindications (for example, certain personal or family histories) and advise on common side effects like nausea, gastrointestinal changes, and hypoglycemia risks if used with other diabetes medications.
It is important to understand that some telehealth programs may prescribe compounded versions of GLP-1 medications. FDA-approved branded drugs (for example, Wegovy® for semaglutide and Mounjaro® for tirzepatide) have specific approval, dosing, and manufacturing standards; compounded alternatives are prescribed under clinician discretion and are not the same as branded formulations. Always discuss risks, benefits, and monitoring plans with the treating clinician.
Futur Health vs Maximus: Medication Quality & Dispensing
Both platforms typically work with U.S.-based pharmacies to dispense medications. Confirm whether a provider supplies FDA-approved brand-name products or compounded prescriptions, as availability, pricing, and labeling differ. Ask about pharmacy accreditation, shipping timelines, temperature-controlled packaging, and return or adverse-event reporting procedures.
Visit Futur Health Pharmacy Details
Futur Health vs Maximus: Customer Experience & Follow-up
Reviews often highlight Futur Health for cost-conscious users who want a fast onboarding experience, while Maximus is mentioned for attentive follow-up and individualized dosing. Delivery windows are commonly within a week after approval, but that can vary by pharmacy and location. Evaluate provider communication, refill management, and return-to-care policies when choosing.
Futur Health vs Maximus: Final Verdict
Choose Futur Health if your priority is lower up-front pricing for semaglutide and fast telehealth onboarding with a required membership. Choose Maximus if you prefer a lower starting price for tirzepatide and program options without a membership fee, with emphasis on clinician follow-up. Both are telehealth options that provide clinician oversight and prescriptions when appropriate, but neither replaces in-person medical evaluation when needed.
Join Futur Health
Get Started with Maximus
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Medication choices should be made in consultation with a licensed clinician. Some telehealth programs prescribe compounded formulations that are not identical to FDA‑approved branded drugs; discuss quality, safety, and monitoring with your provider. ExploreProviders.com and affiliated sites may receive affiliate compensation at no cost to you.
